Besides, molecular docking technology demonstrated that Rh2 had a high affinity with epithelial cell adhesion molecule, which was identified as a potential therapy target in esophageal carcinoma, through establishing hydrogen bonding with Leu240 [22]. The gene discussed is EPCAM; the disease is carcinoma of esophagus.